CDK9-IN-40

• Target:

  Apoptosis|||CDK

• Related Pathways:

  Cell Cycle/Checkpoint|||Apoptosis

• Bioactivity:

  CDK9-IN-40 is an orally active inhibitor of CDK9, with an IC50 of 5.5 nM. It shows reduced activity against CDK1, CDK2, CDK4, and CDK6. CDK9-IN-40 can arrest the cell cycle, induce apoptosis (cell death), and inhibit tumor growth, demonstrating potent anticancer activity.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C